IBD Unit, Careggi University Hospital, Florence, Italy.
Digestive Surgery Unit, Careggi University Hospital, Florence, Italy.
Updates Surg. 2020 Sep;72(3):821-826. doi: 10.1007/s13304-020-00769-8. Epub 2020 Apr 18.
Crohn's disease (CD) patients are generally considered at high risk of post-operative complications with respect to non-CD patients. The primary endpoint of this study is to compare early major complications rates between CD and colon cancer (CC) patients undergoing mini-invasive ileo-colic resections or right hemicolectomies. The secondary endpoint is to evaluate the role of pre-operative medication with anti-TNF as a possible risk factor for post-operative complications. An observational retrospective study was carried on patients who underwent mini-invasive ileocolic resections for CD and right hemicolectomies for CC at Digestive Surgery Unit and IBD Unit, Careggi Univeristy Hospital, from January 1, 2008, to June 1, 2019. Data collected included demographic and clinical informations, pre-operative anti-TNF use, major complications and mortality. Hundred and thirty-three mini-invasive ileocolic resections for CD and 131 mini-invasive right hemicolectomies for CC were included. Early major post-operative complications rates were 4.5% for CD patients and 3% for CC patients (p = 0.535). Anastomotic leak rates were 1.5% in both groups. There was no significant difference in mean length of stay; while, mean operation time was significantly longer in CD patients (p < 0.01). Pre-operative use of anti-TNF was not associated with a higher risk for early major post-operative complications in CD patients. In our institution, CD patients undergoing ileocolic resections or right hemicolectomies with a mini-invasive technique do not have a significantly higher risk of postoperative major complications with respect to CC patients, even when treated with anti-TNF agents within 3 months before surgery.
克罗恩病(CD)患者通常被认为比非 CD 患者在术后并发症方面风险更高。本研究的主要终点是比较接受微创回肠结肠切除术或右半结肠切除术的 CD 和结肠癌(CC)患者的早期主要并发症发生率。次要终点是评估术前使用抗 TNF 作为术后并发症的可能危险因素的作用。对 2008 年 1 月 1 日至 2019 年 6 月 1 日在卡雷吉大学医院消化外科和 IBD 科接受微创回肠结肠切除术治疗 CD 和右半结肠切除术治疗 CC 的患者进行了一项观察性回顾性研究。收集的数据包括人口统计学和临床信息、术前使用抗 TNF、主要并发症和死亡率。纳入了 133 例微创回肠结肠切除术治疗 CD 和 131 例微创右半结肠切除术治疗 CC。CD 患者的早期主要术后并发症发生率为 4.5%,CC 患者为 3%(p=0.535)。两组吻合口漏发生率均为 1.5%。两组的平均住院时间无显著差异;然而,CD 患者的平均手术时间明显更长(p<0.01)。术前使用抗 TNF 与 CD 患者早期主要术后并发症的风险增加无关。在我们的机构中,接受微创技术回肠结肠切除术或右半结肠切除术的 CD 患者与 CC 患者相比,术后发生重大并发症的风险并没有显著增加,即使在术前 3 个月内使用抗 TNF 药物治疗。